UB Paderborn / Katalog / Suche / in CDI

1 – 19 von 19

Sortiert nach

PI3K and AKT: Unfaithful Partners in Cancer

International journal of molecular sciences, 2015-09, Vol.16 (9), p.21138-21152

2015

Volltextzugriff (PDF)

Evolving Significance and Future Relevance of Anti-Angiogenic Activity of mTOR Inhibitors in Cancer Therapy

Cancers, 2017-11, Vol.9 (11), p.152

2017

Volltextzugriff (PDF)

Mechanistic Target of Rapamycin Inhibitors in Renal Cell Carcinoma: Potential, Limitations, and Perspectives

Frontiers in cell and developmental biology, 2021-03, Vol.9, p.636037-636037

2021

Volltextzugriff (PDF)

Fine-Tuning Tumor Endothelial Cells to Selectively Kill Cancer

International journal of molecular sciences, 2017-06, Vol.18 (7), p.1401

2017

Volltextzugriff (PDF)

PGE2-induced colon cancer growth is mediated by mTORC1

Biochemical and biophysical research communications, 2014-09, Vol.451 (4), p.587-591

2014

Volltextzugriff (PDF)

Resistance to mTORC1 Inhibitors in Cancer Therapy: From Kinase Mutations to Intratumoral Heterogeneity of Kinase Activity

Oxidative medicine and cellular longevity, 2017-01, Vol.2017 (1), p.1726078-1726078

2017

Volltextzugriff (PDF)

Prise en charge de la diverticulite aiguë

Schweizer Gastroenterologie Gastroentérologie suisse - Gastroenterologia svizzera, 2021-12, Vol.2 (4), p.128-135

2021

Volltextzugriff (PDF)

Rebound pathway overactivation by cancer cells following discontinuation of PI3K or mTOR inhibition promotes cancer cell growth

Biochemical and biophysical research communications, 2019-06, Vol.513 (3), p.546-552

2019

Volltextzugriff (PDF)

Ondansetron for Low Anterior Resection Syndrome (LARS): A Double-Blind, Placebo-Controlled, Cross-Over, Randomized Study

Annals of surgery, 2024-02, Vol.279 (2), p.196

2024

Volltextzugriff (PDF)

PGE{sub 2}-induced colon cancer growth is mediated by mTORC1

Biochemical and biophysical research communications, 2014-09, Vol.451 (4)

2014

Volltextzugriff (PDF)

Acidic pH reduces VEGF-mediated endothelial cell responses by downregulation of VEGFR-2; relevance for anti-angiogenic therapies

Oncotarget, 2016-12, Vol.7 (52), p.86026-86038

2016

Volltextzugriff (PDF)

Cytokine clearance in serum and peritoneal fluid of patients undergoing damage control surgery with abdominal negative pressure therapy for abdominal sepsis

Pleura and peritoneum, 2021-03, Vol.6 (1), p.31-38

2021

Volltextzugriff (PDF)

Acidic tumor microenvironment abrogates the efficacy of mTORC1 inhibitors

Molecular cancer, 2016-12, Vol.15 (1), p.78-78, Article 78

2016

Volltextzugriff (PDF)

Targeting carbonic anhydrase IX improves the anti-cancer efficacy of mTOR inhibitors

Oncotarget, 2016-06, Vol.7 (24), p.36666-36680

2016

Volltextzugriff (PDF)

Rate of stoma formation following damage-control surgery for severe intra-abdominal sepsis: a single-centre consecutive case series

BJS open, 2021-11, Vol.5 (6)

2021

Volltextzugriff (PDF)

Multidisciplinary treatment of locally advanced rectal cancer

Revue médicale suisse, 2016-06, Vol.12 (523), p.1185

2016

Volltextzugriff (PDF)

Contemporary snapshot of tumor regression grade (TRG) distribution in locally advanced rectal cancer: a cross sectional multicentric experience

Updates in surgery, 2021-10, Vol.73 (5), p.1795-1803

2021

Volltextzugriff (PDF)

Referenz Allgemein- und Viszeralchirurgie – Unterer Gastrointestinaltrakt

1. Auflage.

Volltextzugriff (PDF)

1 – 19 von 19

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(14)
Mit Volltextzugriff
(15)

Publikationsform

Artikel
(17)
Bücher
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(14)
Science & Technology
(14)
Humans
(12)
Angiogenesis
(5)
Animals
(5)
Biochemistry & Molecular Biology
(5)
Cancer
(5)
Cell Biology
(5)
Oncology
(5)
Cell Line, Tumor
(4)
Mtor
(4)
Review
(4)
Surgery
(4)
Tor Serine-Threonine Kinases - Antagonists & Inhibitors
(4)
Biophysics
(3)
Cancer Therapies
(3)
Cell Proliferation - Drug Effects
(3)
Ht29 Cells
(3)
Mechanistic Target Of Rapamycin Complex 1
(3)
Neoplasms - Drug Therapy
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

PI3K and AKT: Unfaithful Partners in Cancer

Evolving Significance and Future Relevance of Anti-Angiogenic Activity of mTOR Inhibitors in Cancer Therapy

Mechanistic Target of Rapamycin Inhibitors in Renal Cell Carcinoma: Potential, Limitations, and Perspectives

Fine-Tuning Tumor Endothelial Cells to Selectively Kill Cancer

PGE2-induced colon cancer growth is mediated by mTORC1

Resistance to mTORC1 Inhibitors in Cancer Therapy: From Kinase Mutations to Intratumoral Heterogeneity of Kinase Activity

Prise en charge de la diverticulite aiguë

Rebound pathway overactivation by cancer cells following discontinuation of PI3K or mTOR inhibition promotes cancer cell growth

Ondansetron for Low Anterior Resection Syndrome (LARS): A Double-Blind, Placebo-Controlled, Cross-Over, Randomized Study

PGE{sub 2}-induced colon cancer growth is mediated by mTORC1

Acidic pH reduces VEGF-mediated endothelial cell responses by downregulation of VEGFR-2; relevance for anti-angiogenic therapies

Cytokine clearance in serum and peritoneal fluid of patients undergoing damage control surgery with abdominal negative pressure therapy for abdominal sepsis

Acidic tumor microenvironment abrogates the efficacy of mTORC1 inhibitors

Targeting carbonic anhydrase IX improves the anti-cancer efficacy of mTOR inhibitors

Rate of stoma formation following damage-control surgery for severe intra-abdominal sepsis: a single-centre consecutive case series

Multidisciplinary treatment of locally advanced rectal cancer

Contemporary snapshot of tumor regression grade (TRG) distribution in locally advanced rectal cancer: a cross sectional multicentric experience

Expertise Koloproktologie

Referenz Allgemein- und Viszeralchirurgie – Unterer Gastrointestinaltrakt

Suchergebnisse filtern